Long-Term Environmental Hypoxia Exposure and Haematopoietic Prolyl Hydroxylase-1 Deletion Do Not Impact Experimental Crohn's Like Ileitis von De Galan, Cara, De Vos, Martine, Hindryckx, Pieter, Laukens, Debby, Van Welden, Sophie

Volltext

Role of integrin expression in the prediction of response to vedolizumab: A prospective real‐life multicentre cohort study von De Galan, Cara, Gonzales, Gerard Bryan, Van Welden, Sophie, Tavernier, Simon Jan, Lobaton, Triana, Van Moerkercke, Wouter, Strubbe, Beatrijs, Peeters, Harald, Macken, Elisabeth, De Vos, Martine, Laukens, Debby, Hindryckx, Pieter

Volltext

The Impact of Vedolizumab and Ustekinumab on Articular Extra-Intestinal Manifestations in Inflammatory Bowel Disease Patients: A Real-Life Multicentre Cohort Study von De Galan, Cara, Truyens, Marie, Peeters, Harald, Mesonero Gismero, Francisco, Elorza, Ainara, Torres, Paola, Vandermeulen, Liv, Jauregui Amezaga, Aranzazu, Ferreiro-Iglesias, Rocio, Holvoet, Tom, Zabana, Yamile, Reverter, Laia Peries, Gonzales, Gerard Bryan, Geldof, Jeroen, Varkas, Gaëlle, De Vos, Martine, Lobatón, Triana

Volltext

Long-term environmental hypoxia exposure and haematopoietic prolyl hydroxylase-1 deletion do not impact experimental Crohn's like ileitis von De Galan, Cara, De Vos, Martine, Hindryckx, Pieter, Laukens, Debby, Van Welden, Sophie

Volltext

The impact of vedolizumab and ustekinumab on articular extra-intestinal manifestations in inflammatory bowel disease patients : a real-life multicentre cohort study von De Galan, Cara, Truyens, Marie, Peeters, Harald, Mesonero Gismero, Francisco, Elorza, Ainara, Torres, Paola, Vandermeulen, Liv, Jauregui Amezaga, Aranzazu, Ferreiro- Iglesias, Rocio, Holvoet, Tom, Zabana, Yamile, Peries Reverter, Laia, Gonzales, Bryan, Geldof, Jeroen, Varkas, Gaëlle, De Vos, Martine, Lobatón Ortega, Triana

Volltext

Safety and effectiveness of vedolizumab and ustekinumab in elderly patients with inflammatory bowel disease : a real-life multicentric cohort study von Holvoet, Tom, Truyens, Marie, De Galan, Cara, Peeters, Harald, Gismero, Francisco Mesonero, Elorza, Ainara, Torres, Paola, Vandermeulen, Liv, Jauregui-Amezaga, Aranzazu, Ferreiro-Iglesias, Rocio, Zabana, Yamile, Reverter, Laia Peries, Geldof, Jeroen, Lobatón Ortega, Triana

Volltext

Safety and Effectiveness of Vedolizumab and Ustekinumab in Elderly Patients with Inflammatory Bowel Disease: A Real-Life Multicentric Cohort Study von Holvoet, Tom, Truyens, Marie, De Galan, Cara, Peeters, Harald, Gismero, Francisco Mesonero, Elorza, Ainara, Torres, Paola, Vandermeulen, Liv, Jauregui-Amezaga, Aranzazu, Ferreiro-Iglesias, Rocio, Zabana, Yamile, Reverter, Laia Peries, Geldof, Jeroen, Lobatón, Triana

Volltext

The impact of vedolizumab and ustekinumab on articular extra-intestinal manifestations in inflammatory bowel disease patients: a real-life multicentric cohort study von De Galan, Cara, Truyens, Marie, Peeters, Harald, Mesonero Gismero, Francisco, Elorza, Ainara, Torres, Paola, Vandermeulen, Liv, Jauregui Amezaga, Aranzazu, Ferreiro-Iglesias, Rocio, Holvoet, Tom, Zabana, Yamile, Peries Reverter, Laia, Gonzales, Gerard Bryan, Geldof, Jeroen, Varkas, Gaëlle, De Vos, Martine, Lobatón, Triana

Volltext

Role of integrin expression in the prediction of response to vedolizumab : a prospective real‐life multicentre cohort study von De Galan, Cara, Gonzales, Bryan, Van Welden, Sophie, Tavernier, Simon, Lobatón Ortega, Triana, Van Moerkercke, Wouter, Strubbe, Beatrijs, Peeters, Harald, Macken, Elisabeth, De Vos, Martine, Laukens, Debby, Hindryckx, Pieter

Volltext

MARKER TO PREDICT RESPONSE TO TREATMENT OF INFLAMMATORY BOWEL DISEASE von DE GALAN, Cara, LAUKENS, Debby

Volltext bestellen